Fingerprint
Dive into the research topics of 'Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab?
D. L. Richardson, F. J. Backes, J. D. Hurt, L. G. Seamon, L. J. Copeland, J. M. Fowler, D. E. Cohn, D. M. O'Malley
Research output: Contribution to journal › Article › peer-review
39
Scopus
citations